Tag: Astero Bio

Gains products that automate the thawing process for high-value biologic therapies Provides access to addressable market projected to exceed $150 million by 2024 BOTHELL, Wash., April 2, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife”) today announced that it has closed the previously announced transaction for the acquisition of Astero Bio Corporation (“Astero”), an innovator in the design, development and... Read more

BOTHELL, Wash., March 14, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife”) today announced that it has entered into an agreement to acquire Astero Bio Corporation (“Astero”), a privately-held innovator in the design, development and commercialization of novel automated thawing devices, for an upfront cash payment of $8.0 million.  This transaction is expected to further strengthen BioLife’s position as a leading... Read more